Farms.com Home   News

JBS To Acquire Cargill's Pork Business.

JBS USA Pork has entered into an agreement to buy Cargill’s U.S. pork business for $1.45 billion.  Included in the acquisition is Cargill’s processing plants in Ottumwa, Iowa and Beardstown, Illinois.  Those plants processed 9.3 million hogs in 2014.  JBS also gets Cargill’s five feed mills in Missouri, Arkansas, Iowa and Texas and four hog farms in Arkansas, Oklahoma and Texas.  Cargill had 161,000 sows at the end of 2014.

Cargill News

JBS first entered the U.S. pork business with the purchase of Swift & Company in 2007.  The wholly-owned subsidiary of JBS SA is the leading processor of pork, beef and lamb in the United States.  The company has the capacity to process more than 50,000 hogs at facilities in Marshalltown, Iowa, Worthington, Minnesota and Louisville, Kentucky.  JBS USA is also a majority shareholder in Pilgrim’s Pride, the second-largest poultry company in the country.

Cargill senior vice president Todd Hall says JBS “places a great deal of value on growing this part of their company to better compete in the marketplace and are willing to invest in its future.”

Completion of the deal is subject to regulatory review and approval.


Trending Video

Revolutionizing Pork Production: Gene Editing and Antimicrobial Stewardship with Banks Baker of PIC

Video: Revolutionizing Pork Production: Gene Editing and Antimicrobial Stewardship with Banks Baker of PIC

In this episode, we explore the transformative advancements in pork production with Banks Baker of PIC. Consumer expectations for high animal care standards, antimicrobial stewardship, and sustainable practices are reshaping the food industry. Innovative solutions and technologies are emerging to meet these demands, fostering sustainable food production.

Gene editing plays a pivotal role in enhancing animal health and aligns with antibiotic stewardship goals in pork production. Baker discusses the potential impact of gene editing on preventing diseases like PRRS and how it parallels successful applications in human healthcare. Challenges and considerations in applying this technology to animal agriculture, particularly in protecting pigs from diseases, are also explored.

PIC's groundbreaking development of a PRRS-resistant pig through gene editing is highlighted, offering broader implications for pig herd health and the significant reduction of antibiotic use. Navigating global regulatory systems presents challenges and opportunities for PIC, and Baker sheds light on the company's approach to gaining approvals worldwide.

Join us in this episode as we delve into the future of pork production, where cutting-edge technologies and sustainable practices are reshaping the industry landscape.